Stockrabit · Analysts
Questions across 2 calls

Kishan Tosniwal

Polar Ventures LLP

Concord Biotech Limited

Concord Biotech Limited CC-Jun25.pdf · 2025-08-11
I have basically two questions. First is, we are into different segments, right, API formulations and right now into CDMO as well. Just wanted to know the profile of our margins. Is the all the businesses are having similar kind of margins or the businesses have different margins?
Okay. And the second question that I have is, I'm seeing the R&D spend that is a percentage of our sales. It was 3.6% in '22, 3.5% in '23, and it has dropped to 2.3%. Can we have a ballpark picture, what is the future that we see? Because as more and more R&D spending increases, our pipeline also increases. Is my understanding correct?

Godawari Power And Ispat limited

Godawari Power And Ispat limited CC-Dec23.pdf · 2024-02-07
Good afternoon. I have one question only. The company is generating good amount of cash flows it is good that the company is again deploying that in expanding the capacity and all but generating such a huge cash flow do you see or is there anything on the Board’s table that there could be a buy back or there could be huge dividend that might come out every year or you might change your dividend policy? That is my only question. Thank you.
Thank you.